Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Thumbnail

Direct oral anticoagulants do not protect patients from COVID-19

The study, published in the Journal of Internal Medicine, explored data from a massive patient registry in Sweden. 

‘We have never seen anything like this’: Risk of death 74% higher when COVID-19 patients develop blood clots

Blood clots are unusually common—and quite fatal—among patients hospitalized with COVID-19.

Aggressive anticoagulation strategies may be harmful for COVID-19 patients

Anticoagulation therapies are an important part of treating COVID-19 patients—but there appears to be no benefit to taking a more aggressive approach.

Thumbnail

Long-term anticoagulation a safe treatment option for elderly AFib patients

Long-term anticoagulation can be recommended for AFib patients 90 years old and older, according to new research. 

Thumbnail

Risk of death, disability after stroke much higher for COVID-19 patients

Experiencing a stroke while your body is already battling COVID-19 can be especially dangerous, this new study suggests. 

Cardiologists detail why blood clots are so common among COVID-19 patients

"In patients with COVID-19, we continue to see a relentless, self-amplifying cycle of inflammation and clotting in the body," one researcher said. 

Boston Scientific gains FDA approval for Ranger drug-coated balloon

The newly approved solution was designed for the treatment of patients with PAD in the superficial femoral artery and proximal popliteal artery.